Singapore, Singapore

Wee Liam Lim

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Life Technologies Corporation, Life Technologies Holdings Pte Limited. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wee Liam Lim

Introduction

Wee Liam Lim is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly with his innovative work on the electroporation pipette. With a total of 1 patent, his inventions have the potential to impact various applications in scientific research and medical technology.

Latest Patents

Wee Liam Lim's most recent patent is the electroporation pipette. This device is designed to facilitate the introduction of substances into cells through the process of electroporation, which can enhance the efficiency of genetic engineering and drug delivery.

Career Highlights

Throughout his career, Wee Liam Lim has worked with prominent companies in the biotechnology sector. He has been associated with Life Technologies Holdings Pte Limited and Life Technologies Corporation, where he contributed to various projects that advanced the field of molecular biology.

Collaborations

Wee Liam Lim has collaborated with several professionals in his field, including Josh Mead and Wui Khen Liaw. These partnerships have allowed him to enhance his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Wee Liam Lim's contributions to the field of biotechnology through his patent on the electroporation pipette exemplify his commitment to innovation. His work continues to inspire advancements in scientific research and medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…